Sleep apnea device maker ResMed agrees to sell its software business MatrixCare to PE firm Frazier for $490M in cash; ResMed bought MatrixCare for $750M in 2018
RBC Capital on ResMed $RMD: “Since COVID the MatrixCare business has underperformed and management had been undertaking a strategic review of its Residential Care Software business, so today's announcement to sell MatrixCare does not come as a surprise. “However the sale price